Welcome equity investors—today’s edition unlocks Orion AI equity research on five US stocks to be benefitted from rescheduling of Marijuana: $TPB ( ▼ 1.55% ), $SMG ( ▲ 0.21% ), $VFF ( ▲ 0.97% ), $IIPR ( ▲ 0.5% ) and $TLRY ( ▼ 7.6% ).

Scores: Fundamental 8 | Analyst Sentiment 9 | Valuation 3 | Catalyst 9 | Technical 6 | Total: 35

Direction: Long

Based on a comprehensive analysis, Turning Point Brands presents a compelling long opportunity for the medium term (1-3 months). The company's fundamental strength is undeniable, highlighted by exceptional Q3 2025 earnings, robust growth in its Modern Oral and Stoker's segments, and confident management raising future guidance. This operational momentum is further supported by strong analyst endorsements, numerous price target increases, and significant institutional investor accumulation, indicating widespread market confidence. While the stock's valuation appears stretched after its recent rally and technical indicators signal an overbought condition, suggesting a potential short-term pullback or consolidation, these are likely temporary corrections within a powerful uptrend. The long-term growth trajectory, strategic investments in high-growth areas like nicotine pouches, and potential as an acquisition target outweigh the immediate technical and valuation concerns. Investors should consider initiating a long position, potentially utilizing any short-term dips as entry points, with a focus on the company's sustained growth and market outperformance.

Read the full report in the attachment, and discover more free reports on our website.

Scores: Fundamental 6 | Analyst Sentiment 7 | Valuation 7 | Catalyst 8 | Technical 5 | Total: 33

Direction: Neutral to Slightly Bullish

Scotts Miracle-Gro presents a complex but potentially rewarding investment opportunity, leaning towards a cautious long position for the medium term. The company is undergoing a significant operational turnaround, evidenced by a return to profitability, robust gross margin expansion, strong free cash flow generation, and substantial debt reduction. Management's high confidence, coupled with a clear strategic roadmap focusing on core U.S. Consumer growth, e-commerce expansion, and the potential divestiture of the challenging Hawthorne segment, underpins a positive fundamental outlook. Analyst sentiment is predominantly bullish, with a consensus 'Moderate Buy' rating and significant upside potential to price targets. Valuation appears attractive on a forward-looking and relative basis, further supported by an appealing dividend yield. However, critical risks persist, notably the negative shareholder equity and 'distressed' solvency scores, which are significant red flags that could limit valuation expansion or trigger volatility. Technically, while the stock shows short-term bullish momentum and has seen a strong recent recovery, it is approaching key resistance levels (200-day MA, upper Bollinger Band) and exhibits overbought signals from the Stochastic Oscillator, suggesting a potential for consolidation or a mean-reversal in the immediate future. The broader market's bullish trend provides a tailwind, but its own short-term overextension adds a layer of caution. Given the strong fundamental improvements and positive market sentiment, a tactical long position could be considered, but with disciplined risk management. Investors should closely monitor the company's progress in addressing its balance sheet issues, the outcome of the Hawthorne divestiture, and how the stock reacts to technical resistance levels. A break above the 200-day MA with strong volume would be a significant bullish confirmation, while failure to overcome this resistance could lead to a pullback towards support levels.

Read the full report in the attachment, and discover more free reports on our website.

Scores: Fundamental 7 | Analyst Sentiment 8 | Valuation 6 | Catalyst 6 | Technical 6 | Total: 33

Direction: Neutral

Village Farms International presents a complex investment case, balancing strong operational improvements and growth catalysts against recent setbacks and valuation concerns. Fundamentally, the company delivered a record Q3 2025 with significant EPS and revenue beats, driven by robust performance in Canadian and Netherlands cannabis segments. The strategic privatization of its Produce segment has streamlined operations and improved the balance sheet, with cash flow generation and profitability showing marked improvement. Management expresses high confidence in global expansion and operational excellence. However, the US cannabis segment remains a drag, and the recent denial of a Texas medical cannabis license is a significant blow to its domestic expansion plans. Substantial insider selling following this news further dampens sentiment. Analyst sentiment is predominantly bullish, with all 'Buy' ratings and an average price target suggesting over 30% upside. Yet, some research reports caution about the stock's valuation after its impressive 346% YTD rally. Technically, $VFF ( ▲ 0.97% ) is in a strong long-term bullish trend, trading well above its 50-day and 200-day moving averages and significantly outperforming the broader market. However, short-term momentum indicators (MACD) show weakening, and the stock is consolidating, suggesting a potential pause or pullback. The macro environment is broadly bullish, but the SPY's short-term overextension could lead to market-wide consolidation. Considering these factors, a Neutral stance is recommended for the medium term (1-3 months). While $VFF ( ▲ 0.97% )'s long-term growth story, particularly in international cannabis, remains compelling, the immediate headwinds from the Texas license denial, insider selling, and slowing short-term technical momentum warrant caution. Investors should await clearer positive catalysts, such as success in Texas Phase II or sustained strong performance in its core cannabis segments, or a more attractive entry point after a potential correction.

Read the full report in the attachment, and discover more free reports on our website.

Scores: Fundamental 3 | Analyst Sentiment 4 | Valuation 7 | Catalyst 6 | Technical 7 | Total: 27

Direction: Neutral to Cautiously Long

Innovative Industrial Properties presents a high-risk, high-reward investment opportunity. The stock is currently experiencing strong short-term bullish momentum, evidenced by a significant price surge and a technical breakout above key moving averages, supported by robust MACD signals. Valuation metrics indicate the stock is deeply undervalued, trading at a substantial discount to its intrinsic value and peers, which could attract contrarian and value investors. The high dividend yield, while appealing, is fundamentally unsustainable with a 180.1% payout ratio, posing a critical risk of a dividend cut that could severely impact the stock price. Operationally, IIPR faces significant headwinds from declining core financials, ongoing tenant defaults, and high credit risk. While strategic diversification into life sciences and the potential for federal cannabis rescheduling offer long-term catalysts, their timing and impact remain uncertain. The broader market is bullish, but also shows signs of short-term overextension. Therefore, a Neutral to Cautiously Long position is recommended for the medium term (1-3 months). Investors considering a long position should be highly speculative, betting on the market continuing to prioritize momentum and potential catalysts over immediate fundamental weaknesses, or that a dividend cut is already priced in. Strict risk management is crucial, as the downside risk from a dividend cut or worsening tenant issues is substantial.

Read the full report in the attachment, and discover more free reports on our website.

Scores: Fundamental 4 | Analyst Sentiment 5 | Valuation 2 | Catalyst 7 | Technical 4 | Total: 22

Direction: Neutral

Based on a comprehensive analysis, Tilray Brands presents a Neutral investment opportunity for the medium term (1-3 months). Fundamentally, the company shows a mixed picture: Q1 FY26 brought positive net income and debt reduction, driven by growth in its cannabis segments and cost savings from Project 420. However, these positives are overshadowed by persistent gross margin pressure, a struggling beverage business, significant shareholder dilution, and consistently low relative rankings against peers, indicating underlying financial fragility. Analyst sentiment is cautiously neutral, with 'Hold' ratings despite high price targets, suggesting that potential upside is largely speculative. Valuation appears stretched, with high EV/EBITDA multiples not justified by current profitability, likely pricing in uncertain future regulatory changes. The primary catalyst remains the highly speculative prospect of US federal cannabis reclassification, which has historically caused extreme price volatility. Technically, the stock is in a short-term bearish trend following a news-driven spike, marked by strong selling volume and trading below its 50-day MA, though it retains long-term support above its 200-day MA. The macro environment, while broadly bullish, shows signs of short-term overextension, offering limited immediate tailwinds. Given the high speculation, fundamental weaknesses, and mixed technical signals, $TLRY ( ▼ 7.6% ) is expected to remain highly volatile, reacting to news flow rather than establishing a clear, sustained trend. Investors should exercise caution and monitor for concrete regulatory developments or sustained fundamental improvements before taking a strong directional stance.

Read the full report in the attachment, and discover more free reports on our website.

Research any US or Hong Kong stock in seconds using Orion AI.

The Wharton Online + Wall Street Prep Private Equity Certificate Program gives you the knowledge and tools top professionals use to analyze investment opportunities.

Plus, join an active network of 5,000+ graduates from all over the world.

Enroll today and save $300 with code SAVE300.

Program begins February 9.

Get the Brochure

Successful investing is often less about making the right moves and more about avoiding the wrong ones. With our guide, 13 Retirement Investment Blunders to Avoid, you can learn ways to steer clear of common errors to help get the most from your $1M+ portfolio—and enjoy the retirement you deserve.

Get your free guide today.

While you were debating if AI would take your job, other people started using it to print money. Seriously.

That's not hyperbole. People are literally using ChatGPT to write Etsy descriptions that convert 3x better. Claude to build entire SaaS products without coding. Midjourney to create designs clients pay thousands for.

The Hustle found 200+ ways regular humans are turning AI into income. Subscribe to The Hustle for the full guide and unlock daily business intel that's actually interesting.

Start making AI money